Literature DB >> 8910295

Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1.

G García-Cardeña1, R Fan, D F Stern, J Liu, W C Sessa.   

Abstract

The regulation of endothelial nitric oxide synthase (eNOS) by phosphorylation is poorly understood. Here, we demonstrate that eNOS is tyrosine-phosphorylated in bovine aortic endothelial cells (BAEC) using 32P metabolic labeling followed by phosphoamino acid analysis and by phosphotyrosine specific Western blotting. Treatment of BAEC with hydrogen peroxide and the protein tyrosine phosphatase inhibitor, sodium orthovanadate, increases eNOS tyrosine phosphorylation. Utilizing a novel immunoNOS assay, the increase in tyrosine phosphorylation is associated with a 50% decrease in the specific activity of the enzyme. Because eNOS is localized in plasmalemma caveolae, we examined if tyrosine phosphorylated eNOS interacts with caveolin-1, the coat protein of caveolae. Immunoprecipitation of eNOS from bovine lung microvascular endothelial cells resulted in the co-precipitation of caveolin-1. Conversely, immunoprecipitation of caveolin-1 resulted in the co-precipitation of tyrosine-phosphorylated eNOS. Thus, tyrosine phosphorylation is a novel regulatory mechanism for eNOS and caveolin-1 is the first eNOS-associated protein. Collectively, these observations provide a novel regulatory mechanism for eNOS and suggest that tyrosine phosphorylation may influence its activity, subcellular trafficking, and interaction with other caveolin-interacting proteins in caveolae.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910295     DOI: 10.1074/jbc.271.44.27237

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  112 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Endothelial nitric oxide in humans in health and disease.

Authors:  P Vallance; A Hingorani
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

3.  Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton.

Authors:  M Stahlhut; B van Deurs
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

4.  The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest.

Authors:  J R Yeh; R Mohan; C M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 5.  Molecular mechanisms of estrogen actions on the vasculature.

Authors:  M P Haynes; K S Russell; J R Bender
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

Review 6.  Caveolin-deficient mice: insights into caveolar function human disease.

Authors:  B Razani; M P Lisanti
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

7.  Solubilization of a membrane protein by combinatorial supercharging.

Authors:  Agnes Hajduczki; Sudipta Majumdar; Marie Fricke; Isola A M Brown; Gregory A Weiss
Journal:  ACS Chem Biol       Date:  2011-01-14       Impact factor: 5.100

8.  Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling.

Authors:  Bo Shen; Lin Gao; Yi-Te Hsu; Grant Bledsoe; Makato Hagiwara; Lee Chao; Julie Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-20       Impact factor: 4.733

9.  Inhibitors caveolin-1 and protein kinase G show differential subcellular colocalization with Nitric oxide synthase.

Authors:  T J Adebola; Raj Usha
Journal:  Afr Health Sci       Date:  2011-12       Impact factor: 0.927

10.  Uncoupling Caveolae From Intracellular Signaling In Vivo.

Authors:  Jan R Kraehling; Zhengrong Hao; Monica Y Lee; David J Vinyard; Heino Velazquez; Xinran Liu; Radu V Stan; Gary W Brudvig; William C Sessa
Journal:  Circ Res       Date:  2015-11-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.